GlassScriptPhysician profile
Julia Lillian Doss
NPI 1093340804
$2,827.58
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $877 · 2022: $1,011 · 2023: $648 · 2024: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $940.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $940.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $720.66 | 2021-2023 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $418.28 | 2021-2024 | Relistor |
| Grt US Holding, INC. | $288.62 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $277.62 | 2021-2023 | Belbuca, Xtampza |
| Biohaven Pharmaceutical Holding Company LTD. | $163.76 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $154.61 | 2021 | |
| Scilex Pharmaceuticals INC. | $115.92 | 2021-2023 | Ztlido |
| Averitas Pharma INC. | $107.27 | 2023-2024 | Qutenza |
| Boston Scientific Corporation | $71.67 | 2023-2024 | Wavewriter Alpha Prime 16 |
| Virtus Pharmaceuticals LLC | $68.54 | 2021 | |
| Allergan, INC. | $63.83 | 2021 | |
| Lundbeck LLC | $52.63 | 2023-2024 | Vyepti |
| Almatica Pharma LLC | $51.68 | 2021 | |
| Pacira Therapeutics, INC. | $43.14 | 2021 | |
| Nevro Corp. | $43.00 | 2024 | Senza |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $36.32 | 2022 | |
| Ipsen Biopharmaceuticals, INC | $25.97 | 2023 | Dysport |
| Si-Bone, INC. | $24.14 | 2021 | |
| Biodelivery Sciences International, INC. | $23.81 | 2021 | |
| Ibsa Pharma INC. | $18.18 | 2023 | Tirosint, Licart |
| Pfizer INC. | $16.60 | 2024 | |
| Depuy Synthes Sales INC. | $14.96 | 2024 | Monovisc |
| Fidia Pharma USA INC. | $14.14 | 2023 | Hymovis, Triluron |
| Redhill Biopharma INC. | $12.23 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Julia Doss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.